Post Acute Long Haulers Covid-19 | CDC | Rainmakers Strategic Solutions

Rainmakers Awarded Centers for Disease Control and Prevention Contract to Support Study of Post-Acute (Long-Haul) COVID-19

Ellicott City, MD – The Centers for Disease Control and Prevention (CDC), Clinical Characterization of Post-Acute COVID-19 awarded Rainmakers Strategic Solutions LLC (Rainmakers) a contract to support research on the long-term effects of COVID-19. The study will characterize the prevalence, symptoms, risk factors, clinical signs, complications, and follow-up needs of people with a history of severe acute respiratory syndrome coronavirus SARS-COV-2 infection.

“Rainmakers is excited to support the CDC in its effort to understand the clinical characteristics and needs of patients suffering from post-acute COVID-19 infection. We are committed to helping our country address the long-term effects of the pandemic. Working with hospitals and the CDC, we look forward to contributing to this important initiative.”

Denise Rainey, President and CEO of Rainmakers

Rainmakers has an extensive background in program management and is already working with the CDC on two Multisystem Inflammatory Syndrome studies, one focusing on children and the other on adults. This project expands our CDC COVID portfolio as Rainmakers will monitor and track three hospitals’ medical record case abstraction activities. As each hospital conducts 300 case abstractions and data quality audits to ensure inter-rater reliability, we will provide technical assistance to the hospitals, inform the CDC of their progress, and help hospitals identify and correct abstraction errors.

Share This

Share on facebook
Share on twitter
Share on linkedin
Share on email
Scroll to Top